BIBLIOGRAPHY
Official Journal of the International Society on Thrombosis and Haemostasis
Volume 5 (2007)
Zwaginga JJ, Sakariassen KS, King MR, Diacovo TG, Grabowski EF, Nash G, Hoylaerts M, Heemskerk JWM, the Biorheology Subcommittee of the SSC of the ISTH. Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3? J Thromb Haemost 2007; 5: (12) 2547-2549.
McLane M A.,Paquette-Straub C , on behalf of the Registry of Exogenous Hemostatic Factors of the SSC of the ISTH. Classification and Nomenclature of disintegrins isolated from snake venoms. J Throm Haemost 5 (9), 1971 (Announcement) Complete version available at http://www.med.unc.edu/isth/ssc/communications/exogenous/disintegrins/disintegrins.htm
Hubbard A R., Weller L J , Johnes S, on behalf of the SSC Subcommittee on Factor VIII and Factor IX. Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116). JTH 2007; 5 (6), 1318-1319
Blombäck M, Konkle B A, Manco-Johnson M J, Bremme K, Hellgren M, Kaaja R, on behalf of the ISTH SSC Subcommittee on Women's Health Issues. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. JTH 2007; 5 (4), 855–858
Toh C-H and Hoots W K.. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. JTH 2007; 5 (3), 604-606.
Longstaff C, Whitton C, Thelwell C and Belgrave D. An international collaborative study to investigate a proposed reference method for the determination of potency measurements of fibrinolytics in absolute units: report on behalf of the Fibrinolysis Subcommittee of the Scientific and Standardization Committee, ISTH. JTH 2007; 5 (2), 412-414.
Muszbek L, Ariëns R A, Ichinose A. Factor XIII: recommended terms and abbreviations. JTH 2007; 5 (1), 181-183.
Volume 4 (2006)
Zwaginga, J. J., Sakariassen, K. S., Nash, G., King, M. R., Heemskerk, J. W., Frojmovic, M. & Hoylaerts, M. F. (2006) Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future. JTH 2006; 4 (12), 2716-2717.
Zwaginga, J. J., Nash, G., King, M. R., Heemskerk, J. W. M., Frojmovic, M., Hoylaerts, M. F. & Sakariassen, K. S. (2006) Flow-based assays for global assessment of hemostasis. Part 1: biorheologic considerations. JTH 2006; 4 (11), 2486-2487.
N. Weinstock and M. Ntefidou. SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniques. JTH 2006; 4: 1825-1827.
R. H. Aster, B. R. Curtis, D. W. Bougie, S. Dunkley, A. Greinacher, T. E. Warkentin and B. H. Chong. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. JTH 2006; 4: 678-679.
Volume 3 (2005)
S. P. Watson, W. F. Bahou, D. Fitzgerald, W. Ouwehand, A. K. Rao and A. D. Leavitt. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. JTH 2005; 3: 2098-2101.
E. Gray and J. Harenberg. Collaborative study on monitoring methods to determine direct thrombin inhibitors lepirudin and argatroban. JTH 2005; 3: 2096-2097.
A. D. Michelson, M. Cattaneo, J. W. Eikelboom, P. Gurbel, K. Kottke-Marchant, T. J. Kunicki, F. M. Pulcinelli, C. Cerletti, A. K. Rao. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. JTH 2005; 3: 1309-1311.
J. E. Sadler, F. Rodeghiero. Provisional criteria for the diagnosis of VWD type 1: on behalf of the ISTH SSC Subcommittee on von Willebrand Factor. JTH 2005; 3: 775-777.
Volume 2 (2004)
A. M. H. P. Van Den Besselaar, T. W. Barrowcliffe, L. L. Houbouyan-Réveillard, J. Jespersen, M. Johnston, L. Poller and A. Tripodi: on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the ISTH. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. JTH 2004; 2: 1946-1953.
Volume 88 (2002)
M. J. Manco-Johnson, E. F. Grabowski, M. Hellgreen, A. S. Kemahli, M. P. Massicotte, W. Muntean, M. Peters, U. Nowak-Göttl. Laboratory Testing for Thrombophilia in Pediatric Patients. Thrombosis and Haemostasis 2002; 88: 155-156.
M. J. Manco-Johnson, E. F. Grabowski, M. Hellgreen, A. S. Kemahli, M. P. Massicotte, W. Muntean, M. Peters, N. Schlegel, M. Wang, U. Nowak-Göttl. Recommendations for tPA Thrombolysis in Children. Thrombosis and Haemostasis 2002; 88: 157-158.
Volume 87 (2002)
M. Frojmovic, G. Nash. Definitions in Biorheology: Cell Aggregation and Cell Adhesion in Flow. Thrombosis and Haemostasis 2002; 87: 771.
Greaves M. Limitations of the Laboratory Monitoring of Heparin Therapy. Thromb Haemost 2002, 87: 163-5.
Jackson CM, White II GC, Barrowcliffe T, Esnouf MP, Jespersen J, Kluft C, Lenahan J. A Reference System Approach to Future Standardization of Laboratory Tests for Hemostasis. Thromb Haemost 2002, 87: 165-170.
Volume 86 (2001)
Taylor Jr FB, Toh C-H, Hoots WK, Wada H, Levi M. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation. Thromb Haemost 2001, 86: 1327-30.
Levi M, Dörffler-Melly J, Johnson GJ, Drouet L, Badimon L. Usefulness and Limitations of Animal Models of Venous Thrombosis. Thromb Haemost 2001, 86: 1331-33.
Kini RM, Morita T, Rosing J. Classification and Nomenclature of Prothrombin Activators Isolated from Snake Venoms. Thromb Haemost 2001, 86: 710-11.
Mazurier C, Rodeghiero F. Recommended Abbreviations for von Willebrand Factor and Its Activities. Thromb Haemost 2001, 86: 712.
Volume 85 (2001)
A. C. Goodeve, J. C. J. Eikenboom, D. Ginsburg, L. Hilbert, C. Mazurier, I.R. Peake, B. J. E. Sadler, F. Rodeghiero. A Standard Nomenclature for von Willebrand Factor Gene Mutations and Polymorphisms. Thrombosis and Haemostasis 2001; 85: 929-931.
G. C. White, II, F. Rosendaal, L. M. Aledort, J. M. Luscher, C. Rothschild, J. Ingerslev. Definitions in Hemophilia. Thrombosis and Haemostasis 2001; 85: 560-75.
Kini RM, Chow G. Exogenous Inhibitors of Platelet Aggregation from Animal Sources. Thromb Haemost 2001, 85: 179-81.
Chow G, Kini RM. Exogenous Factors from Animal Sources that Induce Platelet Aggregation. Thromb Haemost 2001, 85: 177-8 .
Volume 84 (2000)
Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, Lind B, Mannhalter C, Pabinger I, Reitsma PH, Formstone C, Cooper DN, Saito H, Suzuki K, Bernardi F, Aiach M. Protein S Deficiency: A Database of Mutations--Summary of the First Update. Thromb Haemost 2000, 84: 918-934.
Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE. Acquired von Willebrand Syndrome--Data from an International Registry. Thromb Haemost 2000, 84: 345-49 .
Volume 83 (2000)
No official communications published.
Volume 82 (1999)
McCarron BI, Marder VJ, Kanouse JJ, Francis CW. A Soluble Fibrin Standard: Comparabile Dose-response with Immunologic and Functional Assays. Thromb Haemost 1999, 82:145-48 .
Volume 81 (1999)
Sutor AH, von Kries R, Cornelissen EAM, McNinch AW, Andrew M . Vitamin K Deficiency Bleeding (VKDB) in Infancy. Thromb Haemost 1999; 81: 456-61.
White GC, DiMichele D, Mertens K, Negrier C, Peake IR, Prowse C, Schwaab R, Yoshioka A, Ingerslev J. Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates. Thromb Haemost 1999; 81: 462 .
Arocha-Piñango CL, Marchi R, Guerrero B. Inventory of Exogenous Hemostatic Factors Derived from Arthropods. Thromb Haemost 1999; 81: 647-56.
Johnson GJ, Griggs TR, Badimon L. The Utility of Animal Models in the Preclinical Study of Interventions to Prevent Human Coronary Artery Restenosis: Analysis and Recommendations. Thromb Haemost 1999; 81: 835-43 .
Volume 80 (1998)
No official communications published
Vol 79 (1998)
Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International Collaborative Study of the Calibration of a Proposed Reference Preparation for Thromboplastin, Human Recombinant, Plain. Thromb Haemost 1998; 79: 439-43.
Markland FS, Jr. Snake Venom Fibrinogenolytic and Fibrinolytic Enzymes: An Updated Inventory. Thromb Haemost 1998; 79: 668-83 .
Pirkle H. Thrombin-like Enzymes from Snake Venoms: An Updated Inventory. Thromb Haemost 1998; 79: 675-83 .
Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I and the Association of Hemophilia Centre Directors of Canada. A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of Canada. Thromb Haemost 1998; 79: 872-5 .
Vol 78 (1997)
No Official Communications published.
Vol 77 (1997)
Lane DA, Bayston T, Olds RJ, Fitches AC, Cooper DN, Millar DS, Jochmans K, Perry DJ, Okajima K, Thein LL, Emmerich J. Antithrombin Mutation Database: 2nd (1997) Update. Thromb Haemost 1997; 77: 197-211.
Vol 76 (1996)
Burleson AC, Turitto VT. Identification of Quantifiable Hemodynamic Factors in the Assessment of Cerebral Aneurysm Behavior. Thromb Haemost 1996; 76: 118-23.
Mazurier C, Meyer D. Factor VIII Binding Assay of von Willebrand Factor and the Diagnosis of Type 2N von Willebrand Disease. Results of an International Survey. Thromb Haemost 1996; 76: 270-274.
Gray E, Walker D, Heath A, Barrowcliffe TW. Collaborative Study on Assays of Activated FIX (FIXa). Thromb Haemost 1996; 76: 1114-7.
Vol 75 (1996)
Barbui T, Finazzi G, Grassi A, Marchioli R. Thrombosis in Cancer Patients Treated with Hematopoietic Growth FactorsóA Meta-Analysis. Thromb Haemost 1996; 75: 368-71.
Nieuwenhuizen W. A Reference Material for Harmonisation of D-Dimer Assays. Thromb Haemost 1997; 77: 1031-33.
Gandrille S, Borgel D, Ireland H, Lane DA, Simmonds R, Reitsma PH, Mannhalter C, Pabinger I, Saito H, Suzuki K, Formstone C, Cooper DN, Espinosa Y, Sala N, Bernardi F, Aiach M. Protein S Deficiency: A Database of Mutations. Thromb Haemost 1998; 77: 1201-14.
Vol 74 (1995)
Foster PA. The Reproductive Health of Women with von Willebrand Disease Unresponsive to DDAVP: Results of an International Survey. Thromb Haemost 1995; 74: 784-90.
David M, Manco-Johnson M, Andrew M. Diagnosis and Treatment of Venous Thromboembolism in Children and Adolescents. Thromb Haemost 1995; 74: 791-2
Kasper CK, Aronson DL, Davignon G, Foster P, Hillman-Wiseman C, Lusher JM, Manco-Johnson M, Meade JB, Montgomery RR, Rickles FR, White GC, II. Comparison of Six Commercial Plasma References for Factor VIII, Factor IX, and von Willebrand Factor. Thromb Haemost 1995; 74: 987-9
Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the Diagnosis of Lupus Anticoagulants: An Update. Thromb Haemost 1995; 74: 1185-90
Prowse CV. In Vivo Recovery of Factor VIII Following Transfusion: A Survey of Recent Data and Publications to Assess the Influence of Standards Used for Potency Assignment. Thromb Haemost 1995; 74: 1191-6.
A Tripodi, L Poller, AMHP van den Besselaar, PM Mannucci A Proposed Scheme for Calibration of International Reference Preparations of Thromboplastin for the Prothrombin Time. Thromb Haemost 1995; 74: 1368-9.
Foster PA. A Perspective on the Use of FVIII Concentrates and Cryoprecipitate Prophylactically in Surgery or Therapeutically in Severe Bleeds in Patients with von Willebrand Disease Unresponsive to DDAVP: Results of an International Survey. Thromb Haemost 1995; 74: 1370-8.
Brandt JT, Barna LK, Triplett DA. Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants. Thromb Haemost 1995; 74: 1597-1603.
Vol 73 (1995)
South V, Searfoss GH, French S, Cheadle C, Murray E, Howk R, Jaye M, Ricca GA Familial Dysfibrinogenemia and Thrombophilia. Thromb Haemost 1995; 73: 144-50.
Mosesson MW. Terminology for Macromolecular Derivatives of Crosslinked Fibrin. Thromb Haemost 1995; 73: 725-6.
Østerud B, Bajaj MS, Bajaj SP. Sites of tissue Factor Pathway Inhibitor (TFPI) and Tissue Factor Expression under Physiologic and Pathologic Conditions. Thromb Haemost 1995; 73: 873-75.
Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C Deficiency: A Database of Mutations, 1995 Update. Thromb Haemost 1995; 73: 876-89.
Vol 72 (1994)
Mariani G, Ghirardini A, Bellocco R. Immune Tolerance in Hemophilia-Principal Results from the International Registry. Thromb Haemost 1994; 72: 155-8.
Grabowski EF. Guidelines for the Hematologic Evaluation of Contrast Media. Thromb Haemost 1994; 72: 322-4.
Peake I, Tuddenham E. A Standard Nomenclature for Factor VIII and Factor IX Gene Mutations and Associated Amino Acid Alterations. Thromb Haemost 1994; 72: 475-6.
Markwardt F. Inventory of Coagulation Inhibitors from Animals Feeding on Blood. Thromb Haemost 1994; 72: 477-80.
Slack SM, Turitto VC. Flow Chambers and their Standardization for Use in Studies of Thrombosis. Thromb Haemost 1994; 72: 777-81.
Vol 71 (1994)
Stocker K. Inventory of Exogenous Hemostatic Factors Affecting the Thrombin Activating Pathways. Thromb Haemost 1994; 71: 257-60.
Blombäck M, Abildgaard U, van den Besselaar AMHP, Clementson KJ, Dahlbäck B, Esner T, Francis CW, Gaffney P, Gralnick H, Hoyer LW, Johnson GJ, Kasper C, Lane D, Lijnen HR, Lusher JM, Mannucci PM, Poller L, Rapaport SI, Saito H, Stocker K, Thomas D, Barrowcliffe TW, Hemker C, Thorson S, Aronson D, Mann KG, Meyer D, Roberts HR, Dybkær R, Jorgensen K, Olesen H. Nomenclature of Quantities and Units in Thrombosis and Haemostasis (Recommendation 1993). Thromb Haemost 1994; 71: 375
Teng CM, Ko FN, Yu SM. Inventory of Exogenous Factors Affecting Platelet Aggregation Isolated from Plant Sources. Thromb Haemost 1994; 71: 517-19.
Sadler JE. A Revised Classification of von Willebrand Disease. Thromb Haemost 1994; 71: 520-5.
Marsh N. Inventory of Haemorrhagic Factors from Snake Venom. Thromb Haemost 1994; 71: 793-7.
Vol 70 (1993)
Zacharski LR, Donati MB, Rickles FR. Registry of Clinical Trials of Antithrombotic Drugs in Cancer: Second Report. Thromb Haemost 1993; 70: 357-60.
Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M. Antithrombin III Mutation Database: First Update. Thromb Haemost 1993; 70: 361-9.
Falanga A, Barbui T, Rickles FR, Levine MN. Guidelines for Clotting Studies in Cancer Patients. Thromb Haemost 1993; 70: 540-2.
Barrowcliffe TW. Factor VIII and Factor IX Sub-Committee Recommendations for the Assay of High Purity Factor VIII Concentrates. Thromb Haemost 1993; 70: 876-77.
Vol 69 (1993)
Reitsma PH, Poort SR, Bernardi F, Gandrille S, Long GL, Sala N, Cooper DN. Protein C Deficiency: A Database of MutationsóFor the Protein C & S Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 77-84.
van den Besselaar AMPH, Lewis SM, Mannucci PM, Poller L. Status of Present and Candidate International Reference Preparations (IRP) of Thromboplastin for the Prothrombin TimeóA Report of the Subcommittee for Control of Anticoagulation. Thromb Haemost 1993; 69: 85.
Edwards RL, Silver J, Rickles FR. Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 205-13.
von Kries R, Hanawa Y. Neonatal Vitamin K ProphylaxisóReport of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993; 69: 293-5.
Vol 68 (1992)
Mannucci PM. Recommended Protocol for the Study of the Ex Vivo Biological Effects of Virus-Inactivated Plasma Concentrates in Patients with von Willebrand Disease. Thromb Haemost 1994; 68: 84-7.
I Pabinger, CF Allaart, J Hermans, E Briët, RM Bertina, the Protein C Transmitter Study Group. Hereditary Protein C Deficiency: Laboratory Values in Transmitters and Guidelines for the Diagnostic ProcedureóReport on a Study of the SSC Subcommittee on Protein C and Protein S. Thromb Haemost 1992; 68: 470-4.
Boissel JP, Bossard N. Registry of Multicenter Clinical TrialsóTwelfth and Thirteenth Reportó1990-1991. Thromb Haemost 1992; 68: 752-78.
Vol 67 (1992)
Peake I. Registry of DNA Polymorphisms Within or Close to the Human Factor VIII and Factor IX GenesóFor the Factor VIII/IX Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1992; 67: 277-80.
Schmidt B, Andrew M. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thromb Haemost 1979; 67: 381-2.
Vol 66 (1991)
Smith SV, Brinkhous KM. Inventory of Exogenous Platelet Aggregating Agents Derived from Venoms. Thromb Haemost 1991; 66: 259-63.
Pirkle H, Marsh N. Nomenclature of Exogenous Hemostatic Factors. Thromb Haemost 1991; 66: 264.
Boissel JP, Bossard N. Registry of Multicenter Clinical TrialsóEleventh Reportó1989.
Thromb Haemost 1991; 66: 368-83.
Morfini M, Lee M, Messori A. The Design and Analysis of Half-Life and Recovery Studies for Factor VIII and Factor IX. Thromb Haemost 1991; 66: 384-6.
Vol 65 (1991)
Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for Testing and Revised Criteria for Lupus Anticoagulants SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65: 320-22.
Hathaway W, Corrigan J. Report of Scientific and Standardization Subcommittee on Neonatal HemostasisóNormal Coagulation Data for Fetuses and Newborn Infants. Thromb Haemost 1991; 65: 323-25.
Markland FS, Jr. Inventory of a- and b-Fibrinogenases from Snake Venoms For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 438-43.
Pirkle H, Stocker K. Thrombin-Like Enzymes from Snake Venoms: An Inventory For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 444-50.
Teng CM, Huang TF. Inventory of Exogenous Inhibitors of Platelet Aggregation For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 624-6.
Rosing J, Tans G. Inventory of Exogenous Prothrombin Activators For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 627-30.
Bussel J, Kaplan C, McFarland J, and the Working Party of the ISTH. Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia. Thromb Haemost 1991; 65: 631-4.
Vol 64 (1990)
Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Comparison of Test Methods for the Lupus Anticoagulant: International Survey on Lupus Anticoagulants-1 (ISLA-1). Thromb Haemost 1990; 64: 478-84.
Pannekoek H, Lijnen HR, Loskutoff DJ. Recommendations for the Nomenclature of Mutant Fibrinolytic Genes and Their Proteins. Thromb Haemost 1990; 64: 600-3.
Vol 62 (1989)
Owen J. The Utility of Plasma Fibrinopeptide Assays. Thromb Haemost 1989; 62: 807-10.
Brettler DB. Guidelines for SSC CommunicationsóProposed Protocol for the Evaluation of the Effect of High Purity Factor Concentrates on the Immune System of Hemophilia Patients. Thromb Haemost 1989; 62: 811-2.
Francis CW, Mosesson MW. Terminology for Fibrinogen g-Chains Differing in Carboxyl Terminal Amino Acid Sequence. Thromb Haemost 1989; 62: 813-4.
Boissel JP. Subcommittee on Clinical Trials. Registry of Multicenter Clinical TrialsóTenth Reportó1988. Thromb Haemost 1989; 62: 1126-42.
Vol 61 (1989)
Zacharski LR, Donati MB. Registry of Clinical Trials of Antithrombotic Drugs in Cancer. Thromb Haemost 1989; 61: 526-8.
Marlar RA, Montgomery RR, Broekmans AW. Report on the Diagnosis and Treatment of Homozygous Protein C Deficiency. Thromb Haemost 1989; 61: 529-31.
Mannucci PM, Colombo M. Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor Concentrates. Thromb Haemost 1989; 61: 532-4.
Vol 60 (1988)
Colman RW, Müller-Esterl W. Nomenclature of Kininogens. Thromb Haemost 1988; 60: 340-1.
Vol 59 (1988)
Boissel JP. Registry of Multicenter Clinical Trials. Thromb Haemost 1988; 59: 107-119.
Hirsh J, Barrowcliffe TW. Standardization and Clinical Use of LMW Heparin. Thromb Haemost 1988; 59: 333.
Standardization of Factors II, VII, IX, and X in Plasma and Concentrates. ICTH Subcommittee on Factors VIII and IX. Thromb Haemost 1988; Volume 59: 334.
Vol 58 (1987)
Giles AR. Guidelines for the Use of Animals in Biomedical Research. Thromb Haemost 1987; 58: 1078-84.
Gaffney PJ, Curtis AD. A Collaborative Study to Establish the 2 nd International Standard for Tissue Plasminogen Activator (t-PA)*. Thromb Haemost 1987; 58: 1085-7.
Vol 57 (1987)
Francis CW, Alkjaersig N, Glanakis DK, Graeff H, Owen J, Gaffney P, Marder VJ.Terminology for Macromolecular Plasmic Derivatives of Crosslinked Fibrin. Thromb Haemost 1987; 57: 110-1.
Bertina RM. An International Collaborative Study on the Performance of Protein C Antigen Assays. Thromb Haemost 1987; 57: 112-7.
Kisker CT. The Animal Models for Hemorrhage and Thrombosis in the Neonate. Thromb Haemost 1987; 57: 118-22.
Boissel JP. Registry of Multicenter Clinical TrialsóEighth Reportó1986. Thromb Haemost 1987; 57: 361-71.
Vol 56 (1986)
Collen D. Report of the Meeting of the Subcommittee on Fibrinolysis, Jerusalem, Israel, June 2, 1986. Thromb Haemost 1986; 56: 415-16.
Vol 55 (1986)
Goldsmith HL, Turitto VT. Rheological Aspects of Thrombosis and Haemostasis: Basic Principles and Applications. Thromb Haemost 1986; 55: 415-35.
Vol 54 (1985)
Loeliger EA. ICSH/ICTH Recommendations for Reporting Prothrombin Time
in Oral Anticoagulant Control. Thromb Haemost 1985; 54: 155-6.
Marder, VJ, Mannucci, PM, Firkin, BG, Hoyer, LW, Meyer, D. Standard
Nomenclature for Factor VIII and von Willebrand Factor: A Recommendations
by the International Committee on Thrombosis and Haemostasis. Thromb
Haemost 1985; 54: 871-872.
Vol 52 (1984)
Mielke CH. Measurement of the Bleeding Time. Thromb Haemost 1984; 52:210-211.
Packham MA. Standardization of Collagen: Consideration of Current Practices in Testing Collagen-induced Aggregation. Thromb Haemost 1984;52:358-361.
Vol 51 (1984)
Verstraete M. Registry of Prospective Clinical Trials-Sixth Report. Thromb Haemost 1984;51:283-290.
Vol 50 (1983)
Latallo ZS. Retrospective Study on Complications and Adverse Effects of a Treatment with Thrombin-Like EnzymesóA Multicentre Trial. Thromb Haemost 1983; 50: 604-9.
Vol 49 (1983)
Green D, Hougie C, Kazmier FJ, Lechner K, Mannucci PM, Rizza CR, Sultan Y. Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the "Lupus" Anticoagulant. Thromb Haemost 1983; 49: 144-6.
Vol 48 (1982)
Verstraete M. Registry of Prospective Clinical Trials - Fifth Report. Thromb Haemost 1982; 48: 334-8.
Dodds WJ, Joint Report of the Subcommittees on Animal Models of Hemorrhagic and Thrombotic Diseases and on Platelets. Thromb Haemost 1982; 48: 106-7.
Dodds WJ. Report of the Subcommittee on Animal Models of Hemorrhagic and Thrombotic Diseases. Thromb Haemost 1982; 48: 104-5.
Vol 47 (1982)
No Official Communications published.
Vol 46 (1981)
No Official Communications published.
Vol 45 (1981)
OíBrien PF, North WRS, Ingram GIC. The Diagnosis of Mild Haemophilia by the Partial Thromboplastin Time Test. Thromb Haemost 1981; 45: 162-8.
Vol 44 (1980)
Blatt PM, Ménaché D, Roberts HR. A Survey of the Effectiveness of Prothrombin Complex Concentrates in Controlling Hemorrhage in Patients with Hemophilia and Anti-Factor VIII Antibodies. Thromb Haemost 1980; 44: 39-42.
Vol 43 (1980)
Kirkwood TBL, Barrowcliff TW, Thomas DP. An International Collaborative Study Establishing a Reference Preparation for Antithrombin III. Thromb Haemost 1980; 43: 10-5.
Nilsson IM, Meyer D, Hoyer LW, Ingram GIC, Rizza CR. Report of the Subcommittee on Factor VIII Activities. Thromb Haemost 1980; 43: 163-6.
Nilsson IM, Peake IR, Bloom AL, Meyer D, Veltkamp J, Green D. The Relationship Between Ristocetin Co-Factor Activity (VIIIR: Cof) and Factor VIII Related Antigen (VIIIR:Ag). Thromb Haemost 1980; 43: 167-8.
Christensen U. Requirements for Valid Assays of Clotting Enzymes Using Chromogenic Substrates. Thromb Haemost 1980; 43: 169-174.
Nemerson Y, Jackson CM, Aronson DL. Nomenclature Recommendations for Factor VII. Thromb Haemost 1980; 43: 175.
Verstraete M. Registry of Prospective Clinical Trials--Fourth Report. Thromb Haemost 1980; 43: 176-181.
Vol 42 (1979)
Prothrombin Time Standardization. Expert Panel on Oral Anticoagulant Control. Thromb Haemost 1979; 42: 1073-114.
Vol 41 (1979)
Hirsh J. Diagnosis of Venous Thrombosis. Thromb Haemost 1979; 41: 450-3.
Okamoto S. Report of the Subcommittee on Synthetic Substrates and Synthetic Inhibitors of Coagulation Factors and Fibrinolysis Synthetic Inhibitors. Thromb Haemost 1979; 41: 457-9.
Duckert F, McDonagh J. Report of the Subcommittee on Factor XIII. Thromb Haemost 1979; 41: 460-1.
Hedner U. Report of the Subgroup on Fibrinolytic Inhibitors. Thromb Haemost 1979; 41: 622-4.
Barlow GH. Report from the Subcommittee on Heparin. Thromb Haemost 1979; 41: 625-7.
Vol 40 (1978)
Day HJ, Sixma JJ. Report of the Working Party on Platelets. Thromb Haemost 1978: 152-3.
Mustard JF. Platelet Survival. Thromb Haemost 1978: 154-162.
Sixma JJ. Platelet Coagulant Activities. Thromb Haemost 1978: 163-7.
Nossel HL. Secreted Platelet Proteins. Thromb Haemost 1978: 168-174.
Packham MA. Methods for Detection of Hypersensitive Platelets. Thromb Haemost 1978: 175-195.
Vol 39 (1978)
Healy MJR, Ingram GIC. The "Normal Range" in Tests of Haemostasis. Thromb Haemost 1978: 504-9.
Godal HC. Report of the Working Party on Clinical Aspects of Heparin. Thromb Haemost 1978: 510.
Nilsson IM. Report of the Working Party on Factor VIII-Related Antigens. Thromb Haemost 1978: 511-20.
Dodds WJ, Bowie EJW. Report of the Working Party on Animal Models. Thromb Haemost 1978: 521-3.
Hedner U, Abildgaard U. Report on the Joint Meeting of the Task Forces on Nomenclature and Standards of Inhibitors of Coagulation and Fibrinolysis. Thromb Haemost 1978: 524-5.
Verstraete M. Registry of Prospective Clinical Trails: Third Report. Thromb Haemost 1978: 759-67.
Latallo ZS. Report of the Task Force on Clinical Use of Snake Venom Enzymes. Thromb Haemost 1978: 768-74.
Vol 38 (1977)
Gaffney PJ. Report of the Task Force on Standards for Thrombin and Thrombin-Like Enzymes. Thromb Haemost 1977: 562-6.
Jackson CM. Recommended Nomenclature for Blood Clotting Zymogens and Zymogen Activation Products of the International Committee on Thrombosis and Hemostasis. Thromb Haemost 1977: 567-77.
Vol 37 (1977)
Verstraete M. Clinical Investigation Subcommittee. Thromb Haemost 1977: 354.
Owen CA, Dodds WJ. Report of the Working Party on Animal Models. Thromb Haemost 1977: 566-7.
Vol 36 (1976)
Ingram GIC, Hills M. The Prothrombin Time Test: Effect of Varying Citrate Concentration. Thromb Haemost 1976: 230-6.
Ingram GIC, Hills M. Reference Method for the One-Stage Prothrombin Time Test on Human Blood. Thromb Haemost 1976: 237-8.
Verstraete M. Registry of Prospective Clinical Trails. Second Report. Thromb Haemost 1976: 239-50.
Lechner K, Barrett DA, Veltkamp JJ. General Classification System for Hemorrhagic and Thrombotic Disorders. Thromb Haemost 1976: 251-262.
Day HJ, Holmsen H, Zucker MB. Report of the Working Party on Platelets. Thromb Haemost 1976: 263-76.
Vol 35 (1976)
Johnson AJ. Report of the Subcommittee on Standards, 1975. Thromb Haemost 1976: 258-60.
Bangham DR. Report of the Task Force on Heparin Standardization. Thromb Haemost 1976: 472-3.
Jackson CM. Report of the Task Force on Blood Clotting Zymogens and Zymogen Intermediates. Thromb Haemost 1976: 474.
Nilsson IM. Report of the Task Force on Standards of Inhibitors of Blood Coagulationand Fibrinolysis. Thromb Haemost 1976: 475-6.
Aronson DL Report of the Task Force on Standardization of Thrombin and Thrombin-Like Enzymes. Thromb Haemost 1976: 477-8.
Jackson CM, Henriksen RA, Peng CW, Yin ET. Report of the Task Forceon Preparation of Factor Xa (Bovine) PRP (ICTHR). Thromb Haemost 1976: 479-82.
Ingram GIC. Report of the Expert Panel on Oral Anticoagulant Control. Thromb Haemost 1976: 483-4.
Dodds WJ. Report of the Working Party on Animal Models. Thromb Haemost 1976: 746-7.
Ménaché D. Report of the Task Force on Clinical Use of Factor IX Concentrates. Thromb Haemost 1976: 748- 50.
Vol 34 (1975)
Robertson IPJ, Gaffney PJ, Bangham DR. Standard for Human Thrombin. Thromb Diath Haemorrh 1975: 3-19.
Kirkwood TBL, Campbell PJ, Gaffney PJ. A Standard for Human Plasmin. Thromb Diath Haemorrh 1975: 20-31.
Vol 33 (1975)
Ménaché D. Clinical Use of Factor IX Concentrates. Thromb Diath Haemorrh 1974: 597-99.
Ménaché D. Factor IX Concentrates. Thromb Diath Haemorrh 1974: 600-5.
Hoofnagle JH, Aronson D, Roberts H. Serologic Evidence for Hepatitis B Virus Infection in Patients with Hemophilia B - A Multicenter Study. Thromb Diath Haemorrh 1974: 606-9.
Roberts HR, Blatt PM. Post-transfusion Hepatitis Following the Use of Prothrombin Complex Concentrates. Thromb Diath Haemorrh 1974: 610-6.
Kingdon HS, Lundblad RL, Veltkamp JJ, Aronson DL. Potentially Thrombogenic Materials in Factor IX Concentrates. Thromb Diath Haemorrh 1974: 617-31
Cash JD, Dalton RG, Middelton S, Smith JK. Studies on the Thrombogenicity of Scottish Factor IX Concentrates in Dogs. Thromb Diath Haemorrh 1974: 632-9
Kasper CK. Thromboembolic Complications. Thromb Diath Haemorrh 1974: 640-4.
Ménaché D, Roberts HR. Summary Report and Recommendations of the Task Force Members and Consultants. Thromb Diath Haemorrh 1974: 645-7.
Day HJ, Holmsen H, Zucker MB. Methods for Separating Platelets from Blood and Plasma. Thromb Diath Haemorrh 1974: 648-54.